Littleton Radiation Oncology One of Several New Cancer Treatment Centers Now Offering BSD Medical’s Hyperthermia Therapy
SALT LAKE CITY, July 10 /PRNewswire-FirstCall/ — BSD Medical Corp. today announced that Littleton Radiation Oncology has joined BSD Medical’s growing group of U.S. customers, with their acquisition and installation of a BSD-500 Hyperthermia System in their Littleton, Colorado facility. Littleton is a suburb of Denver. This new system will increase their ability to treat cancer patients at their facility.
“With a large and long time patient experience using hyperthermia therapy in treating cancer patients, it is a great pleasure to bring this highly effective, proven technology to this region of the country,” said David P. Schreiber, MD, CEO at Littleton Radiation Oncology.
“We are pleased to welcome Littleton Radiation Oncology as a new proponent of hyperthermia therapy for cancer,” said Hyrum A. Mead, president of BSD Medical Corp. “Dr. David Schreiber has published a number of articles on the benefits of hyperthermia in the treatment of cancer and brings years of experience in using this therapy. We are pleased to offer the benefits of hyperthermia therapy to his patients with the BSD-500.”
About BSD Medical Corporation
BSD Medical Corp. is the leading developer of systems used to deliver hyperthermia therapy for the treatment of cancer. Hyperthermia therapy is used to kill cancer directly and increase the effectiveness of companion radiation treatments for certain tumors. Research has also shown promising results from the use of hyperthermia therapy in combination with some chemotherapy agents as well as tumor reduction prior to surgery. For further information visit BSD Medical’s website at http://www.bsdmedical.com/ or BSD’s patient website at http://www.treatwithheat.com/.
About Littleton Radiation Oncology
Littleton Radiation Oncology located in Littleton, Colorado, was opened in May 2000 by Dr. David Schreiber, MD. Although focused initially on prostate cancer, Littleton Radiation Oncology has been able to take existing technologies and expand their uses to various other types of malignancies. These include breast cancer, gynecological cancer, colon cancer, brain tumors, and others. For further information visit Littleton Radiation Oncology’s website at http://www.littletonradiationoncology.com/.
Statements contained in this press release that are not historical facts are forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995. All forward-looking statements are subject to risks and uncertainties detailed in the Company’s filings with the Securities and Exchange Commission.
BSD Medical Corp.
CONTACT: Hyrum A. Mead of BSD Medical Corp., +1-801-972-5555, or fax,+1-801-972-5930, email@example.com
Web site: http://www.bsdmedical.com/http://www.treatwithheat.com/